My Cart

StemRegenin 1 (GMP)

StemRegenin 1 or SR1 (GMP-grade) is an antagonist of the aryl hydrocarbon receptor (AHR). SR1 promotes the expansion human hematopoietic stem cells and the generation of progenitor cells. This product is GMP-grade and can be used in cell and gene therapy research applications. Bulk discounts and custom packaging available.

Grouped product items
SKUSIZEPRICE QTY
SML39BG10 mg
$1,275.00
- +
SML39KG50 mg
$3,675.00
- +
Details
Resources
Reviews
Description
Specifications
More Information
SKUSML39GMP
Alternative NamesSR1, regenin
Chemical Name4-[2-[[2-Benzo[b]thien-3-yl-9-(1-methylethyl)-9H-purin-6-yl]amino]ethyl]phenol
Chemical FormulaC24H23N5OS
Molecular Weight429.54
CAS Number1227633-49-9
PubChem ID46199207
Purity≥98% (HPLC)
Physical AppearanceOff-white to yellow
ShippingRoom Temperature
Storage4°C and protect from light

StemRegenin 1 (SR1) is an antagonist of the aryl hydrocarbon receptor (AHR). SR1 promotes ex vivo expansion of CD34+ human hematopoietic stem cells and the generation of CD34+ hematopoietic progenitor cells from non-human primate induced pluripotent stem cells. SR1 has been shown to collaborate with UM729 in preventing differentiation of acute myeloid leukemia (AML) cells in culture. SR1 also stimulates the proliferation and differentiation of CD34+ hematopoietic progenitor cells into dendritic cells.

SRI promotes maintenance and expansion of human hematopoietic stem cells in culture (Boitano et al., Csaszar et al.) and stimulates differentiation of CD34+ hematopoietic progenitor cells into functional human dendritic cells (Thordardottir et al.). SRI also promotes hematopoietic differentiation of induced pluripotent stem cells (iPS). (Gori et al.) and collaborates with UM729 in preventing differentiation of AML cells in cancer research (Pabst et al.).

Cell Types: Cancer Cells and Cell Lines, Dendritic Cells, Hematopoietic Stem and Progenitor Cells, Leukemia/Lymphoma Cells, Pluripotent Stem Cells
Applications: Differentiation, Expansion

Resources

References
  • Jackson et al,. 2017. Targeting the aryl hydrocarbon receptor nuclear translocator complex with DMOG and Stemregenin 1 improves primitive hematopoietic stem cell expansion. Stem Cell Res. 21 124 PMID: 28445828.
  • Genovese et al., 2014. Targeted genome editing in human repopulating haematopoietic stem cells. Nature 510 235 PMID: 24870228
  • Boitano et al., 2010. Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells. Science 329 1345 PMID: 20688981
  • Koide et al., 2016. Aryl hydrocarbon receptor antagonist StemRegenin 1 promotes the expansion of human promyelocytic leukemia cell line, NB4. Anticancer Res. 36 3635 PMID: 27354634

Reviews
Write Your Own Review
You're reviewing:StemRegenin 1 (GMP)
Your Rating